Affymax to Present at the BIO CEO & Investor Conference

  Affymax to Present at the BIO CEO & Investor Conference

BIO CEO & Investor Conference 2013

Business Wire

PALO ALTO, Calif. -- February 6, 2013

Affymax, Inc. (Nasdaq: AFFY) today announced that John Orwin, the company's
chief executive officer, will present at the 15^th Annual BIO CEO & Investor
Conference on Tuesday, February 12, 2013 at 9:30 a.m. Eastern Time (6:30 a.m.
Pacific Time) in New York City.

A live webcast of the presentation will be available on the investors section
of the company's website at http://www.investors.affymax.com/events.cfm. A
replay will also be available for 30 days following the presentation.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California.
Affymax's mission is to discover, develop and deliver innovative therapies
that improve the lives of patients with kidney disease and other serious and
often life-threatening illnesses.

The company's first marketed product, OMONTYS^® (peginesatide) Injection, was
approved by the U.S. Food and Drug Administration (FDA) in March 2012. For
additional information, please visit www.affymax.com.

Contact:

Affymax, Inc.
Alexandra Santos, 650-812-8961
Associate Director, Corporate Communications
 
Press spacebar to pause and continue. Press esc to stop.